Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators

Similar Items

• Evaluating the Combined Effect of Comorbidity and Prostate-Specific Antigen Kinetics on the Risk of Death in Men After Prostate-Specific Antigen Recurrence
  od: Wo, Jennifer Y., i dr.
  Izdano: (2009)
• Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial
  od: Giacalone, Nicholas J., i dr.
  Izdano: (2016)
• Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
  od: Sanford, Nina N., i dr.
  Izdano: (2016)
• Impact of Time to Testosterone Rebound and Comorbidity on the Risk of Cause-Specific Mortality in Men with Unfavorable-Risk Prostate Cancer
  od: McDuff, Susan G. R., i dr.
  Izdano: (2018)
• Low Testosterone at First PSA Failure and Assessment of the Risk of Death in Men with Unfavorable-Risk Prostate Cancer Treated on Prospective Clinical Trials
  od: Atkins, Katelyn M., i dr.
  Izdano: (2017)